MedICAL ADVOCATES
Children
  Hepatitis C Drugs

General Reports
Interferon
Peginterferon
Ribavirin






 
Pediatric HCV Pediatric Main Page Home Page
General Reports
         

     Journal Papers, Abstracts, and Commentaries
 
  A WEEK-IN REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
Current treatment options and response rates in children with chronic hepatitis C.
Wirth S
 World J Gastroenterol. 2012 Jan 14;18(2):99-104.
 Paper

Pediatric issues in new therapies for hepatitis B and C.
Schwarz KB.
Curr Gastroenterol Rep 2003 Jun;5(3):233-9
 Abstract

Drug treatment of pediatric chronic hepatitis B.
Sokal E .
Paediatr Drugs 2002;4(6):361-9
Abstract
Interferon
         

Journal Papers, Abstracts, and Commentaries

 
Interferon treatment in children with chronic hepatitis C: Long-lasting remission in
 responders, and risk for disease progression in non-responders.
Bortolotti F, Iorio R, Nebbia G, et al
 Dig Liver Dis. 2005 May;37(5):3
 Abstract
 
Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C
and haemophilia followed at a pediatric haemophilia treatment center.
Puetz J, Thrower M, Kane R, Bouhasin J.
Haemophilia. 2004 Jan;10(1):87-93.
 Abstract
 
Virus genotype 1b and long-term response to interferon alpha monotherapy in children with
chronic hepatitis C.
Mozer-Lisewska I, Sluzewski W, et al
Eur J Pediatr. 2003 Nov;162(11):755-9.
Abstract
 
Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis
Di Ciommo V, Russo P, Rava L, Caprino L.
J Viral Hepat. 2003 May;10(3):210-4
 Abstract
 
Efficacy of interferon-alpha treatment in Japanese children with chronic hepatitis C.
Nakashima E, Fujisawa T, Kimura A
J Gastroenterol Hepatol. 2003 Apr;18(4):411-4.
 Abstract
 
Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic
hepatitis C.
Wirth S, Lang T, Gehring S, Gerner P.
Hepatology. 2002 Nov;36(5):1280-4.
 Abstract
 
 
Does interferon and ribavirin combination therapy increase the rate of treatment response
in children with hepatitis C?
Suoglu D OD, Elkabes B, Sokucu S, Saner G.
J Pediatr Gastroenterol Nutr. 2002 Feb;34(2):199-206.
Abstract
 
An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.
Jacobson KR, Murray K, Zellos A, Schwarz KB. 
Pediatr Gastroenterol Nutr 2002 Jan;34(1):52-8
Abstract
Peginterferons
         
Peginterferon/Ribavirin

          Journal Papers, Abstracts, and Commentaries
 
 
Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic
hepatitis C in children.
Pawlowska M, Pilarczyk M, Halota W.
Med Sci Monit. 2010 Nov 30;16(12):CR616-621
 Abstract

The Combination of Ribavirin and Peginterferon Is Superior to Peginterferon and Placebo for Children
and Adolescents Chronic Hepatitis C.
Schwarz KB, Gonzalez-Peralta RP, Murray KF, et al
Gastroenterology. 2010 Oct 28.
Abstract

Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With
Pegylated Interferon.
Narkewicz MR, Rosenthal P, Schwarz KB,  et al
J Pediatr Gastroenterol Nutr. 2010 May 25
 Abstract

High sustained virologic response rates in children with chronic hepatitis C
receiving peginterferon alfa-2b plus ribavirin.
Wirth S, Ribes-Koninckx C, Calzado MA, et al
J Hepatol. 2010 Feb 4.
 Abstract

Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic
hepatitis C viral infection.
 Murray KF, Rodrigue JR, González-Peralta RP, et al 
Clin Trials. 2007;4(6):661-73
 Abstract
 
Early virological response in children with chronic hepatitis C treated with pegylated
interferon and ribavirin.
 Kowala-Piaskowska A, Słuzewski W, Figlerowicz M, Mozer-Lisewska I.
Infection. 2007 Jun;35(3):175-9
 Abstract
 
Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in
serum and peripheral blood mononuclear cells in children with chronic hepatitis C.
Majda-Stanislawska E, Bednarek M, Jozwiak B, et al
Acta Gastroenterol Belg. 2006 Apr-Jun;69(2):187-90.
 Abstract

Factors influencing early virological response in children with chronic hepatitis C
treated with pegylated interferon and ribavirin.
Kowala-Piaskowska A, Sluzewski W, Figlerowicz M, et al   
Hepatol Res. 2005 Aug 5;
Abstract
 
Peginterferon alfa-2a
 
          Journal Papers, Abstracts, and Commentaries
 
  Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With
Pegylated Interferon.
Narkewicz MR, Rosenthal P, Schwarz KB,  et al
J Pediatr Gastroenterol Nutr. 2010 May 25
 Abstract

Peginterferon alfa-2b

          Journal Papers, Abstracts, and Commentaries
 
 
Efficacy and Safety of Peginterferon-alpha2b and Ribavirin Combination Therapy in Children
With Chronic Hepatitis C Infection.
 Jara P, Hierro L, de la Vega A, et al 
Pediatr Infect Dis J. 2008 Jan 2
 bstract

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with
chronic hepatitis C.
 Wirth S, Pieper-Boustani H, Lang T, et al
Hepatology. 2005 May;41(5):1013-8.
Abstract
Ribavirin
         

          Journal Papers, Abstracts, and Commentaries

  Combination therapy with ribavirin and interferon in a cohort of children with hepatitis C and
haemophilia followed at a pediatric haemophilia treatment center.
Puetz J, Thrower M, Kane R, Bouhasin J.
Haemophilia. 2004 Jan;10(1):87-93.
 Abstract

Pediatric HCV Pediatric Main Page Home Page

Photo by Caroline Jacoby Courtesy of M/MC Photoshare at www.jhuccp.org/mmc  and is protected by current copyright law 
Pediatric Internet Resource Center
Hepatitis C Drugs